Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Gliwel-M:
Gliwel-M is a combination tablet containing Glibenclamide and Metformin, designed to help manage blood glucose levels in individuals with type 2 diabetes. This synergistic combination offers a dual-action approach to improving glycemic control, making it an effective treatment for patients who have not responded adequately to monotherapy.
Uses of Gliwel-M:
Control of blood glucose levels in type 2 diabetes mellitus
Used in patients who have not achieved sufficient glucose control with diet and exercise alone
Aids in the prevention of complications related to uncontrolled diabetes, such as cardiovascular issues
Benefits of Gliwel-M:
Dual action with Glibenclamide to increase insulin secretion and Metformin to reduce glucose production in the liver
Helps to improve insulin sensitivity and reduce blood sugar levels effectively
Reduces the risk of hypoglycemia, providing a safer option for patients
Convenient fixed-dose combination reduces the pill burden for patients
Mechanism of Action of Gliwel-M:
Glibenclamide: Stimulates the pancreas to release more insulin, which helps lower blood sugar levels, particularly after meals.
Metformin: Reduces glucose production in the liver, enhances insulin sensitivity, and increases glucose uptake by muscles, leading to improved overall blood sugar control.
Gliwel-M is a reliable and convenient treatment option that helps patients manage their diabetes more effectively, alongside lifestyle interventions and regular monitoring.